James Mackin - CryoLife Pres Chairman
| CYL Stock | EUR 27.45 0.20 0.72% |
Insider
James Mackin is Pres Chairman of CryoLife
| Age | 56 |
| Phone | 770 419 3355 |
| Web | https://artivion.com |
James Mackin Latest Insider Activity
Tracking and analyzing the buying and selling activities of James Mackin against CryoLife stock is an integral part of due diligence when investing in CryoLife. James Mackin insider activity provides valuable insight into whether CryoLife is net buyers or sellers over its current business cycle. Note, CryoLife insiders must abide by specific rules, including filing SEC forms every time they buy or sell CryoLife'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
James Mackin over six months ago Disposition of 59225 shares by James Mackin of Artivion at 16.3 subject to Rule 16b-3 |
CryoLife Management Efficiency
The company has return on total asset (ROA) of 0.0122 % which means that it generated a profit of $0.0122 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.0656) %, meaning that it generated substantial loss on money invested by shareholders. CryoLife's management efficiency ratios could be used to measure how well CryoLife manages its routine affairs as well as how well it operates its assets and liabilities.Management Performance
| Return On Equity | -0.0656 | |||
| Return On Asset | 0.0122 |
CryoLife Leadership Team
Elected by the shareholders, the CryoLife's board of directors comprises two types of representatives: CryoLife inside directors who are chosen from within the company, and outside directors, selected externally and held independent of CryoLife. The board's role is to monitor CryoLife's management team and ensure that shareholders' interests are well served. CryoLife's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, CryoLife's outside directors are responsible for providing unbiased perspectives on the board's policies.
| CPA CPA, VP Officer | ||
| James Mackin, Pres Chairman | ||
| Dennis Maier, VP Operations | ||
| Joshua Wells, Sr Devel | ||
| Marshall MD, VP Officer | ||
| Jean Esq, Gen VP | ||
| John Davis, VP Marketing | ||
| Matthew Getz, VP HR |
CryoLife Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is CryoLife a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.0656 | |||
| Return On Asset | 0.0122 | |||
| Profit Margin | (0.06) % | |||
| Operating Margin | 0.05 % | |||
| Current Valuation | 796.78 M | |||
| Shares Outstanding | 40.56 M | |||
| Shares Owned By Insiders | 4.69 % | |||
| Shares Owned By Institutions | 87.40 % | |||
| Price To Earning | 303.28 X | |||
| Price To Book | 2.05 X |
Currently Active Assets on Macroaxis
Other Information on Investing in CryoLife Stock
CryoLife financial ratios help investors to determine whether CryoLife Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in CryoLife with respect to the benefits of owning CryoLife security.